← All stocks

ENANTA PHARMACEUTICALS INC

ENTA No buying or selling

CIK 0001177648 #3326 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Luly Jay R.

President and CEO

—

871,871

$12.41M

+7.6%

Or Yat Sun

Chief Scientific Officer

—

374,854

$5.33M

+0.4%

MELLETT PAUL J

Chief Fin. & Admin Officer

—

95,884

$1.36M

0.0%

Luu Brendan

Chief Business Officer

—

41,634

$592.45K

+6.5%

Kieffer Tara Lynn

Chief Product Strategy Officer

—

33,925

$482.75K

+4.9%

Rottinghaus Scott T.

Chief Medical Officer

—

23,787

$338.49K

+26.6%

Trout Harry R. III

See Remarks

—

16,348

$232.63K

+49.8%

Capps Kathleen S.

See Remarks

—

8,377

$119.20K

+43.7%

Kowalsky Matthew Paul

Chief Legal Officer

—

3,591

$51.10K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 29 Sep 2016